Plus, ADP said private payrolls grew by 2.369 million in June, United Airlines said it is adding 25,000 flights next month, and Beyond Meat is rising after news its meatless burger patties will soon be available in grocery stores in China.
Read MorePlus, coronavirus cases surpassed 10 million globally and 2.5 million in the U.S., Chesapeake Energy filed for bankruptcy, and Beyond Meat shares are down after a double downgrade.
Read MoreTrade Setup Buy Target $36.90 Sell Target $45.42 Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. The company’s lead products include ARV-110, proteolysis targeting chimeras (PROTAC) that is in phase I clinical trial targeting the androgen receptor (AR) protein for the treatment of men […]
Read MoreBuy Price: $6.25 or better Sell Price: TradersPro Sell Signal IVERIC bio, Inc., a biopharmaceutical company, develops novel therapies to treat ophthalmic diseases with a focus on age-related and orphan retinal diseases. The company is developing Zimura, an inhibitor of complement factor C5, which is in Phase IIb clinical trials for the treatment of geographic […]
Read MoreTrade Setup Buy Target $10.43 Sell Target $12.34 CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops a novel class of investigational antibody therapeutics based on its Probody technology platform for the treatment of cancer.
Read MorePlus, stocks are up after President Trump said the U.S.-China phase one trade deal is still “fully intact” after confusion following a statement from trade advisor Peter Navarro, six global investors inked a $20.7 billion agreement with the Abu Dhabi National Oil Company, and Wirecard’s former CEO has been arrested.
Read MorePlus, Gilead is gearing up to test an inhaled version of its antiviral drug remdesivir in the treatment of COVID-19, Microsoft is acquiring a cybersecurity startup, and Wirecard shares tanked after it said the $2.1 billion missing from its balance sheet likely doesn’t exist.
Read MoreTrade Setup Buy Target $31.63 Sell Target $36.42 Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient’s immune system to eradicate cancer cells. The company’s lead product candidates include lifileucel that is in Phase II clinical trial for the treatment of metastatic […]
Read MoreThese 9 stocks have exploded higher since the market bottom.
Read MoreTrade Setup Buy Target $14.27 Sell Target $15.19 XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of antibody therapies for treating oncology, inflammatory conditions, and infectious diseases.
Read MoreBuy Price: $5.00 or better Sell Price: TradersPro Sell Signal Kadmon Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes small molecules and biologics primarily for the treatment of inflammatory and fibrotic diseases.
Read MoreTrade Setup Stocks found in this category are low priced stocks priced between .50 and $1, with at least 50k shares of average shares trading per day. The stocks are pausing a trend either up or down, with a new bar over the prior day open or close. These are high reward to risk stocks with the […]
Read MoreBuy Price: $5.50 or better Sell Price: TradersPro Sell Signal Bioanalytical Systems, Inc., doing business as Inotiv, a pharmaceutical development company, provides drug discovery and development services, and analytical instruments for pharmaceutical, biotechnology, academic, and government organizations in the United States, rest of North America, the Pacific Rim, Europe, and internationally. It operates through two […]
Read MorePlus, retail sales jumped a record 17.7% in May, a sturdy from the University of Oxford showed a common anti-inflammatory drug proves to save lives among those sickest with COVID-19, and McDonald’s shares are slightly higher on improved sales in May.
Read MoreTrade Setup Stocks found in this category are low priced stocks priced between .50 and $1, with at least 50k shares of average shares trading per day. The stocks are pausing a trend either up or down, with a new bar over the prior day open or close. These are high reward to risk stocks with the […]
Read More